| YR Ending | Q1 Sep | Q2 Dec | Q3 Mar | Q4 Jun | | 2017 | | | | | | 2016 | -0.13 | | | | | 2015 | -0.12 | -0.11 | -0.11 | -0.11 | | 2014 | -0.16 | -0.15 | -0.15 | -0.15 | | 2013 | -0.13A | -0.10A | -0.19A | -0.13 | | 2012 | -0.06A | -0.06A | -0.11A | -0.09A | | 2011 | -0.20A | -0.23A | -0.20A | -0.17A | | 2010 | -0.52A | -0.44A | -0.30A | -0.30A | | 2009 | -0.71A | -0.79A | -0.62A | -0.55A | | 2008 | -0.40A | -0.43A | -0.51A | -0.68A | | 2007 | -0.21A | -0.40A | -0.35A | -0.39A | | 2006 | -0.25A | -0.23A | -0.24A | -0.31A | | 2005 | -0.19A | -0.16A | -0.16A | -0.17A |
|
| YR Ending | FISC YR Annual | NUM Brokers (FISC) | CAL YR Annual | NUM Brokers (CAL) | | 2017 | -0.05 | 5 | | | | 2016 | -0.33 | 6 | -0.19 | 5 | | 2015 | -0.46 | 6 | -0.41 | 5 | | 2014 | -0.46 | 9 | -0.49 | 1 | | 2013 | -0.55 | 9 | -0.62 | 3 | | 2012 | -0.33 | 6 | -0.43 | 0 | | 2011 | -0.81 | 8 | -0.49 | 8 | | 2010 | -1.55 | 10 | -1.03 | 9 | | 2009 | -2.67 | 11 | -2.13 | 11 | | 2008 | -2.04 | 10 | -2.69 | 10 | | 2007 | -1.36 | 9 | -1.57 | 11 | | 2006 | -1.02 | 8 | -1.16 | 10 | | 2005 | -0.69 | 5 | | |
|
Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Array BioPharma Inc.. Please note that any opinions, estimates or forecasts regarding Array BioPharma Inc. performance made by these analysts (and therefore the Mean estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Array BioPharma Inc. or its management. Array BioPharma Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.  | 
